Avecho Biotechnology Limited (ASX:AVE)

Australia flag Australia · Delayed Price · Currency is AUD
0.0040
-0.0010 (-20.00%)
Jul 25, 2025, 12:03 PM AEST
-20.00%
Market Cap14.28M
Revenue (ttm)1.13M
Net Income (ttm)-3.12M
Shares Out3.17B
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume511,135
Average Volume2,870,524
Open0.0050
Previous Close0.0050
Day's Range0.0040 - 0.0050
52-Week Range0.0010 - 0.0090
Beta1.09
RSI49.09
Earnings DateMay 26, 2025

About Avecho Biotechnology

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery. Its human health portfolio covers delivery of pharmaceutical products for pain and dermatology applications through gels, injectables, and patches. In additio... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1992
Employees 15
Stock Exchange Australian Securities Exchange
Ticker Symbol AVE
Full Company Profile

Financial Performance

In 2024, Avecho Biotechnology's revenue was 1.13 million, an increase of 139.19% compared to the previous year's 473,551. Losses were -3.12 million, -9.15% less than in 2023.

Financial Statements

News

There is no news available yet.